Immunotherapy for microsatellite-stable colorectal cancer: overcoming resistance and exploring novel therapeutic strategies
Microsatellite-stable (MSS) colorectal cancer (CRC), comprising 85% to 95% of all CRC cases, represents a significant therapeutic challenge in the era of cancer immunotherapy. Unlike microsatellite instability-high tumors that demonstrate remarkable responses to immune checkpoint inhibitors, MSS CRC...
Збережено в:
| Автор: | |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Korean Society of Coloproctology
2026-02-01
|
| Серія: | Annals of Coloproctology |
| Предмети: | |
| Онлайн доступ: | http://coloproctol.org/upload/pdf/ac-2025-01354-0193.pdf |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|